Capital World Investors - Mar 31, 2025 SCHEDULE 13G Report for Allogene Therapeutics, Inc. Common Stock (ALLO)

Filing Manager: Capital World Investors
Reporting Manager: Capital World Investors
Security: Allogene Therapeutics, Inc. Common Stock
Symbol: ALLO
Shares outstanding: 219M shares
Disclosed Ownership: 12.3M shares
Ownership: 5.6%
Form type: SCHEDULE 13G
Date filed: 5/13/2025, 11:44 AM
Date of event: Mar 31, 2025
Next filing: Nov 13, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Capital World Investors	5.6%	12.3M	12.3M	0	Jae Won Chung	Vice President and Senior Counsel II, Capital Research and Management Company